|
Thursday 31st March 2022 |
Text too small? |
Cannasouth Limited (NZX: CBD , Cannasouth), today released its Annual Report for the year ended 31 December 2021.
Changes versus 2021 Unaudited Preliminary Results
On 1 March 2022 Cannasouth released to the market its preliminary results for the year ended 31 December 2021 (Preliminary Results). The table in the attached '2021 Annual Report Announcement' document summarises the key results.
The Preliminary Results were prepared on the basis that the accounting treatment for the acquisition of Midwest Pharmaceutics NZ Ltd and Cannasouth Cultivation Ltd was subject to audit. The reclassification of pre-acquisition transactions has no cash flow impacts.
Included with this announcement are the following documents:
• 2021 Annual Report
• Revised Results Announcement Form
-ENDS-
No comments yet
KPG - Kiwi Property Green Bond offer closed
PFI - Capital Change Notice - FY27 LTI Scheme Grant
IKE - 1H FY27 Performance Update
SUM - Summerset Appoints Sue Matthews as Independent Director
GNE - FY27 Q1 Performance Report
FPH - F&P Healthcare statement regarding cyber incident
HGH - Heartland Group confirms leadership endorsements
October 22nd Morning Report
VCT - Operational Performance for the 3 months ended 30 Sept 2026
SKL - Skellerup with strong start, forecasts growth for FY27